Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Fagard

Showing results (81-90 of 514) with videos related to

Pageof 52
Sort By:
Lancet (London, England)|April 26, 1980
Captopril and agranulocytosisJ Staessen, R Fagard, P Lijnen, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 7, 2003
Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblastsP Lijnen, V Petrov, K Rumilla, et al.
Journal of Human Hypertension|October 1, 1988
The effect of ageing on the plasma renin-angiotensin-aldosterone system in elderly hypertensive patientsE Bielen, R Fagard, P Lijnen, et al.
The American Journal of Cardiology|January 1, 1995
Relation of left ventricular mass and filling to exercise blood pressure and rest blood pressureR Fagard, J Staessen, L Thijs, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Effect of bendrofluazide on the renin-angiotensin-aldosterone system and prostaglandins in captopril-resistant hypertensive patientsP Lijnen, J Staessen, R Fagard, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|September 1, 1982
Hemodynamic response to converting enzyme inhibition at rest and exercise in humansR Fagard, P Lijnen, L Vanhees, et al.
Circulation|January 1, 1982
Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patientsR Fagard, C Bulpitt, P Lijnen, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1989
Possible biochemical mechanisms involved in the antihypertensive drug-induced changes in serum lipoproteinsP Lijnen, R Fagard, J Staessen, et al.
Journal of Cardiovascular Pharmacology|October 1, 1988
Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertensionP Lijnen, R Fagard, J Staessen, et al.
Experientia|July 15, 1981
Active and inactive renin in dog plasma before and after bilateral nephrectomyJ Staessen, P Lijnen, R Fagard, et al.
Pageof 52

Showing results (81-90 of 514) with videos related to

Sort By:
Pageof 52
Lancet (London, England)|April 26, 1980
Captopril and agranulocytosisJ Staessen, R Fagard, P Lijnen, et al.
Methods and Findings in Experimental and Clinical Pharmacology|May 7, 2003
Transforming growth factor-beta 1 promotes contraction of collagen gel by cardiac fibroblasts through their differentiation into myofibroblastsP Lijnen, V Petrov, K Rumilla, et al.
Journal of Human Hypertension|October 1, 1988
The effect of ageing on the plasma renin-angiotensin-aldosterone system in elderly hypertensive patientsE Bielen, R Fagard, P Lijnen, et al.
The American Journal of Cardiology|January 1, 1995
Relation of left ventricular mass and filling to exercise blood pressure and rest blood pressureR Fagard, J Staessen, L Thijs, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
Effect of bendrofluazide on the renin-angiotensin-aldosterone system and prostaglandins in captopril-resistant hypertensive patientsP Lijnen, J Staessen, R Fagard, et al.
Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology|September 1, 1982
Hemodynamic response to converting enzyme inhibition at rest and exercise in humansR Fagard, P Lijnen, L Vanhees, et al.
Circulation|January 1, 1982
Response of the systemic and pulmonary circulation to converting-enzyme inhibition (captopril) at rest and during exercise in hypertensive patientsR Fagard, C Bulpitt, P Lijnen, et al.
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1989
Possible biochemical mechanisms involved in the antihypertensive drug-induced changes in serum lipoproteinsP Lijnen, R Fagard, J Staessen, et al.
Journal of Cardiovascular Pharmacology|October 1, 1988
Short-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertensionP Lijnen, R Fagard, J Staessen, et al.
Experientia|July 15, 1981
Active and inactive renin in dog plasma before and after bilateral nephrectomyJ Staessen, P Lijnen, R Fagard, et al.
Pageof 52